Dr. Alexander works at the interface cancer genomics, clinical trials, and global pediatric oncology with three areas of research focus
1) Investigation of new cancer therapeutics through early phase clinical trials for high risk acute leukemia
2) Exploration of the biology of minimal residual disease in acute lymphoblastic leukemia, through RNA sequencing and epigenetic studies, at both a bulk and single cell level. The ultimate goal is to develop more rational therapeutic targets for patients with persistent MRD.
3) Development of a novel genomic sequencing approach for cancer diagnostics in low and middle income counties.